Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATHENS: Acetylcysteine and Theophylline for CIN Prophylaxis
NCT00492518Phase 4Completed
- Sponsor
- Technical University of Munich
- Start
- Feb 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of acetylcysteine and theophylline in contrast-induced nephropathy (CIN) (4 arms), sponsored by Technical University of Munich. Primary endpoint: Incidence of Contrast-Induced Nephropathy at 48 hours. Started Feb 2002; status: completed.
02
Drugs
acetylcysteinetheophylline
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT00492518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00492518.